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Antiproliferative Role of Dopamine:
Loss of D2 Receptors Causes Hormonal Dysfunction
and Pituitary Hyperplasia
Adolfo Saiardi, Yuri Bozzi, Ja-Hyun Baik,* to the thyrotrophs, the somatotrophs, and finally the
lactotrophs, which produce thyroid-stimulating hor-and Emiliana Borrelli
mone (TSH), growth hormone (GH), and prolactin (PRL),Institut de GeÂ neÂ tique et de Biologie
respectively (Slabaugh et al., 1981; Frohman, 1987;MoleÂculaire et Cellulaire
Gage et al., 1996). It has been shown that the expressionCNRS/INSERM/ULP, BP 163
of Prop-1, a paired-like homeodomain transcription67404 Illkirch Cedex
factor (Sornson et al.,1996), and Pit-1/GHF1, a transcrip-C. U. de Strasbourg
tion factor of the POU homeodomain gene family, areFrance
early prerequisites for the determination of this lineage
(Li et al., 1990; Rhodes et al., 1994). Subsequently, hypo-
thalamic factors such as growth hormone-releasing hor-Summary
mone (GHRH) are required for the proliferation of these
cells (Mayo, 1992; Lin et al., 1992; Godfrey et al., 1993).The function of dopamine (DA) in the nervous system
Interestingly, the proliferation and maintenance of so-is paralleled by its neuroendocrine control of pituitary
matotrophs and lactotrophs are controlled in oppositegland functions. Here, we document the neuroendo-
ways by intracellular cAMP levels. Namely, while soma-crine function of dopamine by studying the pituitary
totroph proliferation requires the activation of cAMP sig-gland of mice lacking DA D2 receptors (D2R). These naling, lactotroph maintenance is negatively controlledmice present a striking, progressive increase in lacto-
by dopamine-mediated inhibition of the same pathway
troph number,which ultimately leads to tumors in aged
(Weiner et al., 1988). A linear relationship in the develop-
animals. Females develop tumors much earlier than ment of lactotrophs from somatotrophs has been dem-
males. An estrogen-mediated lactotroph proliferation onstrated by cell ablation studies (Behringer et al., 1988;
cannot account for this sexual dimorphism, since D2R- Borrelli et al., 1989). Thus, establishment of the lacto-
null females are hypoestrogenic and, thus, have estro- trophs is the last differentiation step within the thyro-
gen levels similar to males. In contrast, prolactin levels somato-mammotroph lineage. After birth, lactotroph
are six times higher in females than in males. We show proliferation appears to be regulatedby estrogens (Lieb-
that active prolactin receptors are present in the pitu- erman et al., 1983). Thus, dopamine (DA) and estrogens
itary and their expression increases in concomitance are thought to act in an opposing fashion on lactotroph
with tumor expansion. These results point to prolactin growth. Indeed, estrogen treatment of rats induces lac-
as an autocrine proliferative factor in the pituitary totroph proliferation and may lead to pituitary tumors
gland. Additionally, they demonstrate an antiprolifera- (Elias and Weiner, 1987). Dopamine can block this effect
tive function for DA regulated through D2 receptor acti- and has also been shown to aid regression of prolactino-
vation. mas, fairly frequent human pituitary tumors (Bansal et
al., 1981). This suggests that a balance exists between
Introduction these positive and negative signals, which is important
for themaintenance of the lactotroph lineage.The mech-
anisms underlying estrogen stimulation of lactotrophThe development of the pituitary gland is a remarkable
proliferation and DA-mediated regression of prolactino-process in which the temporally coordinated activity
mas have yet to be elucidated.of different factors establishes cell identity (Voss and
Here, we analyze the physiological relevance of dopa-Rosenfeld, 1992; Borrelli, 1994; Andersen and Rosen-
minergic control to the development of the pituitaryfeld, 1994). In rodents, the pituitary gland is composed
gland by studying mice lacking the DA D2 receptor (D2R)of the adenohypophysis, which comprises the anterior
(Baik et al., 1995). The D2R is highly expressed in the(AL) and intermediate (IL) lobes, and the neurohypo-
pituitary and in thebrain, where it exists in two molecularphysis, which constitutes theposterior lobe (PL). Adeno-
forms, D2L and D2S (Picetti et al., 1997). These two iso-hypophysis development has been extensively studied,
forms have been shown to couple different G-proteinsdue to its relatively simple structure and low cellular
(Montmayeur et al., 1993; Guiramand et al., 1995).complexity. The availability of cellular markers, repre-
We show that the negative control over prolactin syn-senting the specific hormones secreted by each cell
thesis mediated by DA is lost in D2R-null mice. Interest-type, has allowed tracing of these cells during develop-
ingly, these mice show a time-dependent proliferationment. These include the gonadotrophs, which secrete
of lactotrophs, which leads to anterior pituitary tumorsfollicle stimulating hormone (FSH) and luteinizing hor-
in older animals. The time of onset of these tumors is
mone (LH); the corticotrophs, which produce adeno-
delayed in males. This sexual dimorphism is due to the
corticotropin (ACTH); and the melanotrophs, which pro-
different levels of prolactin in the two genders. We sug-
duce a-melanocyte-stimulating hormone (a-MSH) and gest that prolactin acts as an autocrine growth factor
b-endorphin (b-End). The thyro-somato-mammotroph through the activation of pituitary PRL receptors (PRL-R)
lineage deserves special mention. This lineage gives rise (Boutin et al., 1988). Thus, DA, via the D2Rs, appears to
act not only as a key regulator of pituitary hormone
secretion, but also as a master-switch directing the deci-*Present address: Medical Research Center (Molecular Biology Sec-
sion of the somato-mammotroph lineage to differentiatetion), College of Medicine, Yonsei University, CPO Box 8044, Seoul,




Absence of Dopaminergic Sites
in D2R-Null Pituitaries
Dopamine function in the central nervous system is par-
alleled by its neuroendocrine control of pituitary func-
tions (Frohman,1987). The physiological effects induced
by DA are mediated through the interaction with specific
membrane receptors (Gingrich and Caron, 1993). In the
pituitary, DA acts through receptors of the D2-like family
expressed in the lactotrophs and melanotrophs (Auteli-
tano et al., 1989). Indeed, DA is thought to control the
synthesis and release of prolactin in the AL and of hor-
mones produced by the processing of proopiomelano-
cortin (POMC) in the IL (Chen et al., 1983; Cote et al.,
1986; Elsholtz et al., 1991; Ben-Jonathan, 1994).
We used D2R-null mice to establish whether the ab-
sence of D2Rsmight becompensated byoverexpression
of other D2-like receptors (D3 and D4) previously reported
in the pituitary (Herroelen et al., 1994; Valerio et al.,
1994). We performed in situ ligand binding studies on
pituitaries from wild-type (WT) and D2R-null mice. Two
D2-like specific receptor antagonists were utilized, [125I]-
iodosulpride and [3H]-spiperone. The first binds to D2R
and D3R, while the second binds to D2R and D4R with
similar affinities (Seeman and Van Tol, 1994). In situ
binding analysis using [125I]-iodosulpride, at a final con-
centration of 0.3 nM, reveals a strong labeling of the AL
Figure 1. Ligand Binding Autoradiography of WT and D2R2/2 Pitu-and IL of WT mice pituitaries (Figure 1, WT). In contrast,
itariesno labeling is detected in the pituitary from D2Rknockout
Ligand binding experiments were performed with [125I]-iodosulpride.mice (Figure 1, D2R2/2). Similar results were obtained
The AL and IL of the WT pituitary are strongly labeled, whereaswhen [3H]-spiperone was used (not shown). The lack
labeling is completely absent in the D2R2/2 pituitary. Results areof binding of these compounds in D2R-null pituitaries representative of three independent experiments. AL, anterior lobe;
indicates that neither D3R nor D4R can compensate for IL, intermediate lobe; PL, posterior lobe. Scale bar, 500 mm.
the absence of D2R, and we also question their reported
presence in WT pituitaries.
Functional Consequences of D2R AbsencePituitary Hyperplasia in D2R-Null Mice
on Pituitary Hormones
A key question concerns the role of DA acting through
The enlargement of the AL and IL correlates with thethe D2R on the normal differentiation program of the location of the two cell types that normally express D2Rs:pituitary gland. Thus, to characterize the pituitary phe-
lactotrophs and melanotrophs (Coteet al., 1986; Elsholtznotype of D2R knockouts, we first performed histological
et al., 1991; Ben-Jonathan, 1994). Thus, we analyzedanalyses of pituitary sections from D2R2/2 and WT ani-
whether this abnormality might influence other parame-mals. The pituitaries of 4-month-old animals (n . 10) of
ters such as the expression of pituitary hormones. Totalboth sexes and genotypes were analyzed. Cryostat and
RNA extracted from pituitaries of 4-month-old D2R2/2paraffin sections were prepared and stained with hema-
mice and WT littermates was analyzed by Northern blottoxylin-eosin. Sections obtained from D2R-null 4-month-
using specific probes for the different pituitary hor-old females and males compared with WT littermates
mones (Figure 3). A threefold increase of PRL mRNAare presented in Figure 2A. Strikingly, it is evident that
expression and a three- to fourfold increase of POMCthe overall size of the pituitary is augmented in both
gene expression were found in pituitaries from D2R-nullmale and female D2R2/2 mice, although this enlargement
mice, compared with WT littermates. The increase ofis less pronounced in males (Figure 2A). Diamidinophe-
POMC expression is restricted to melanotrophs, as re-nolindole (DAPI) staining of pituitary cell nuclei in these
vealed by RNAse protection experiments, in which thesections revealed a hyperplasia of the IL (Figure 2B, top
AL was separated from the IL (data not shown). This ispanel). The surface of the intermediate lobe showed a
in agreement with the restriction of D2R expression to40% increase in D2R2/2 mice (WT 5 0.28 6 0.03 mm2;
the melanotrophs and not the corticotrophs, the otherD2R2/2 5 0.4 6 0.04 mm2; n 5 40 sections from six
pituitary cell type which expresses POMC.pituitaries of each genotype), which resulted in a corre-
The level of expression of the hormones produced bysponding increase in cell number but not in cell density.
the other AL cell types was evaluated by using probesConversely, in the AL,both cell number and densitywere
specific for thyrotrophs (b-TSH, aGSU), somatotrophssimilarly increased, as demonstrated by hematoxylin-
(GH) and gonadotrophs (b-FSH, b-LH, aGSU). The resulteosin staining (Figure 2B, bottom panel). This indicates
of this analysis shows a 20% decrease in the expressionthat lack of dopaminergic control leads to pituitary cell
proliferation. of GH, while no difference in b-TSH expression (Figure
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Figure 2. Histological Analysis of the Pitu-
itary Gland of WT and D2R2/2 Mice
(A) Hematoxylin-eosin staining of pituitary
cryostat sections from 4-month-old WT and
D2R2/2 females and males, as indicated. Scale
bar, 200 mm.
(B) The top row shows DAPI staining of the IL
from WT and D2R2/2 female pituitaries. Dotted
lines indicate the boundaries between the dif-
ferent lobes. The bottom row shows hema-
toxylin-eosin coloration of the AL. Original
magnification, 2003. AL, anterior lobe; IL, in-
termediate lobe; PL, posterior lobe.
3) was observed. Considering the increased size of the indicates that in the adult, DA, through D2Rs, has an
important role in maintaining lactotrophs and somato-AL, these results are in agreement with a reduction of
GH-positive cells and an increase in TSH-positive cells. trophs, which share common developmental origins
with thyrotrophs. The availability of genetic mutants,We also confirmed that the reduction in GH is not depen-
dent upon an altered expression of GHRH, since no as well as cell ablation studies (Behringer et al., 1988;
Borrelli et al., 1989), enabled the development of thedifference in its levels was observed in hypothalamic
RNA from WT and D2R-null mice (data not shown). Inter- thyro-somato-mammotroph lineage to be elucidated.
The analyses of these model systems have demon-estingly, b-LH and b-FSH expression was reduced by
20% (Figure 3). The reduction of gonadotrophin mRNAs strated that these cellsderive from a common precursor,
and that expression of Pit-1 (Li et al., 1990; Rhodes etis probably dependent on the increased PRL level, since
PRL exerts a negative control on the hypothalamic re- al., 1994) and Prop-1 (Sornson et al., 1996) is an essential
requirement for fate cell commitment. Later in develop-lease of gonadotrophin-releasing hormone (Li and Pel-
letier, 1992). In agreement, Northern analysis of aGSU, ment, GHRH is required for their proliferation (Mayo,
1992; Lin et al., 1992; Godfrey et al., 1993).the common subunit of glycoproteic hormones ex-
pressed specifically by gonadotrophs and thyrotrophs Estrogens have been shown to stimulate lactotroph
proliferation in the adult (Lieberman et al., 1983),(Pierce and Parsons, 1981; Akerblom et al., 1990; Ken-
dall et al., 1995), showed no differences in the expres- whereas DA has been only indirectly implicated in the
control of the proliferation of this lineage. Indeed, treat-sion of this gene (Figure 3). Thus, D2R absence leads to
alterations of AL hormone expression. ment with dopaminergic agonists helps the regression
of prolactinomas, PRL-producing human pituitary tu-
mors (Bansal et al., 1981). However, alone, these obser-The Loss of D2Rs Affects the Thyro-Somato-
Mammotroph Cell Lineage vations do not clearly define the role of DA in the normal
physiology of lactotrophs, nor the molecular mechanismIn addition to increased PRL expression, loss of D2R in
the AL also results in a decrease of GH expression. This of its action.
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shifts in the proportion of their respective hormone-
producing cells. These analyses (Figure 4) illustrated
that the PRL mRNA elevation is at least in part depen-
dent on an increase in the proportion of lactotrophs in
D2R-null mice. A robust PRL expression is visible in
the tissue from D2R-null mice (Figure 4). An increased
number of lactotrophs is also evident, with PRL positive
cells appearing smaller and more compact (Figure 4).
Thyrotrophs constitute a very scarce population (2%±
5%) of AL pituitary cells (Gage et al., 1996). Interestingly,
a twofold increase in the number of thyrotrophs was
observed in the pituitary of D2R-null mice (40 6 12 cells/
section; WT 5 22 6 9 cells/section; n 5 24 sections
from four pituitaries of each genotype; P , 0.05, Stu-
dent's t-test) (Figure 4, b-TSH). This was evaluated by
the counting of cells containing autoradiographic grains
in serial sections of the gland. These data indicate that
the expansion of the AL might also involve these cells.
In spite of the increased cell number, no significant in-
crease of b-TSH plasma levels was present in D2R-null
mice (n 5 8 males and 9 females) as compared with
WT (n 5 10 males and 9 females). On the contrary,
we estimated a 25% decrease in the number of GH-
expressing cells in these mice as compared with WT
littermates (WT 5 214 6 45 cells/0.1 mm2; D2R-null 5
162 6 30 cells/0.1 mm2; n 5 200 counting fields from
four pituitaries of each genotype; P , 0.001, Student's
t-test) (Figure 4, GH). In agreement with this finding, GH
plasma levels were decreased by 25% and 35% in D2R-
null males and females, respectively (n 5 10±12 animals
per experimental group).
The number of the remaining AL cells, gonadotrophs
and corticotrophs,appeared unaltered (data not shown).
Therefore, the major effect in the AL caused by the loss
of D2Rs concerns the cell proportion within the thyro-
somato-mammotroph lineage. Thus, DA controls lacto-
troph proliferation, and in its absence more somato-
trophs are converted into lactotrophs. This effect could
be due to an imbalanced estrogen stimulation of lacto-
troph proliferation in D2R-null mice.
Hyperprolactinemia in the Absence
of Dopaminergic Control
Consistent with the massive increase of lactotrophs,
quantitation of serum PRL revealed very high levels of
this hormone in D2R-null mice. Adult female PRL plasma
levels increased from 24.2 6 5.4 ng/ml serum in the WT
(n 5 10) to 264 6 35.2 ng/ml in the mutant (n 5 10),
whereas in adult males, levels increased from 7.7 6 0.8
ng/ml in the WT (n 5 10) to 41.1 6 7.2 ng/ml in the
mutants (n 5 10). D2R-null homozygotes showed a 10.9-
Figure 3. Pituitary Hormone Expression in WT and D2R2/2 Mice and 5.3-fold higher PRL serum content in females and
Northern blot analysis of PRL, POMC, GH, b-TSH, b-FSH, b-LH, and males, respectively. Importantly, the elevation of PRL in
aGSU pituitary mRNAs from WT (1/1) and D2R mutant (2/2) mice. the serum is much greater than what would have beenThe amounts of total RNA per sample were as follows: PRL, 0.5 mg
predicted from the increase in the levels of mRNA and(females) and 2 mg (males); GH and aGSU, 1 mg; POMC, 3 mg;
lactotroph number alone (Figures 3 and 4).b-TSH, b-FSH, and b-LH, 5 mg. Results are representative of three
independent experiments. Neuroregulation of PRL secretion is multifactorial. Al-
though the hypothalamic control is mainly negative and
exerted by DA, positive signals are also needed to in-
duce the acute secretion of PRL and include the thyro-We therefore focused our attention on the study of
this lineage in D2R-null animals. In situ hybridization ex- tropin-releasing hormone (TRH) (Jacobset al., 1971) and
vasoactive intestinal peptide (VIP) (Abe et al., 1985).periments were performed to confirm whether the ob-
served change in GH and PRL mRNA levels was due to Consequently, we analyzed the expression of these two
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Figure 4. In Situ Analysis of PRL, GH, and
b-TSH mRNA Expression in the Pituitary
Gland of WT and D2R2/2 Female Mice
Serial sections from pituitaries of 4-month-
old WT and D2R2/2 females were hybridized
with mouse PRL, GH and b-TSH probes. Re-
sults are representative of four different ex-
periments. Dotted lines indicate the border
between AL and IL. AL, anterior lobe; IL, inter-
mediate lobe; PL, posterior lobe. Scale bar,
75 mm.
positive acting factors in theD2R-null mice. Interestingly, to affect the expression of hypothalamic hormones that
regulate PRL secretion. Thus, the observed increase ofin situ hybridization analysis of hypothalamic tissue from
D2R-null and WT littermates showed similar levels of serum PRL seems to be directly linked to the absence
of dopaminergic control on the secretion of these hor-expression of the TRH and VIP genes in both genotypes
(Figure 5). This indicates that lack of D2R does not seem mones. Therefore, D2R appears to exert a stronger inhib-
itory control over prolactin release than on RNA tran-
scription/stability. One possibility is that, in the absence
of D2Rs, the tonic PRL release from lactotrophs is lost,
and the hormone is constitutively secreted in D2R-null
mice. Accordingly, in spite of the increased lactotroph
population in D2R-null mice, immunoblot analysis using
anti-PRL antibodies revealed a 50% decrease of PRL
in the pituitary gland of D2R-null mice (not shown).
Hypoestrogenism in D2R Deficient Mice
Extensive evidence clearly demonstrates stimulation of
lactotroph cell proliferation by estrogens. Moreover, es-
trogens have been shown to play a permissive role in
directing the somato-mammotroph lineage toward lac-
totroph differentiation (Boockfor et al., 1986). Thus, in
the absence of the negative control exerted by D2R on
lactotrophs, estrogens might stimulate the proliferation
of these cells. However, it is known that high PRL levels
Figure 5. In Situ Analysis of VIP and TRH mRNA Expression in the lead to hypoestrogenism, which in turn results in infertil-
Hypothalamus of WT and D2R2/2 Mice ity in humans (Wang et al., 1980; Dorrington and Gore-
Serial sections from the brain of WT and D2R2/2 females were hybrid- Langton, 1981). Interestingly, D2R-null animals have aized with mouse VIP and TRH probes. Similar results were obtained
reduced fertility (Baik et al., 1995), indicating perturba-in three independent experiments. SC, suprachiasmatic nuclei. The
tions of the pituitary±gonadal axis.arrowheads in the TRH pictures indicate the periventricular hypo-
thalamic region. Scale bar, 125 mm. To gain further insight into the mechanismsunderlying
Neuron
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Figure 6. Analysis of the Estrous Cycle in WT
and D2R2/2 Female Mice
Vaginal smears from a WT and a D2R2/2
mouse stained by hematoxylin-eosin. In WT
females, the estrous cycle has a characteris-
tic periodicity, with an estrus every 4 days.
Diestrus (WT in [A]) is characterized by the
prevalence of lymphocytes (small nucleated
cells) in the vaginal fluid. During proestrus
(WT in [B]), the vaginal fluid begins to contain
nucleated epithelial cells, due to the keratini-
zation of the upper layer of the vaginal epithe-
lium. In the estrous stage (WT in [C]), cells in
the vaginal fluid are only keratinocytes. Dur-
ing metaestrus (WT in [D]), the keratinization
of the upper layers of the vaginal epithelium
decreases, and both keratinocytes and lym-
phocytes can be observed. Conversely, all
vaginal smears collected from D2R2/2 mice
reveal the continuous presence of lympho-
cytes (D2R2/2, A±D), indicating a complete al-
teration of the estrous cycle. Original magnifi-
cation, 403.
lactotroph proliferation, we assessed the estrogen lev- presented a striking difference in the PRL plasma levels
els in D2R mutant mice. Comparative analyses of the compared with mutant males (females, 264 6 35.2
estrous cycle of D2R-null females (n 5 5) and WT mice ng/ml; males, 41.1 6 7.2 ng/ml). While WT females have
(n 5 5) were performed. Interestingly, while a rhythmic a PRL concentration three times higher than males, it
periodicity with a recognizable estrus is evident every is six times higher in the knockouts. Therefore, thephysi-
4 days in WT females, the estrous cycle of D2R mutants ological causes for the differences in the PRL levels
was completely altered (Figure 6). Indeed, estrus was between males and females are different in WT and
observed only once in a month in D2R-null females. D2R-null mice. In WT females, high PRL plasma levels
These data strongly indicate that high levels of PRL are due to the synergistic contribution of high estrogens
perturbate gonadal function in female mutants. In con- and a larger number of lactotrophs. The increase of PRL
trast, D2R-null males display normal spermatogenesis. in D2R-null females versus males must be solely linked
Next, we analyzed estrogen levels in D2R-null and to the enrichment for lactotrophs.
WT animals. Since the mutant females have a sporadic
estrus, it was impossible to collect blood at definite
Is Prolactin a Prolactin-Releasing Factor?cycle stages. We thus pooled blood samples from 13
A key question arises from these results: what deter-individuals of each group (housed in different cages) to
mines the increase in the lactotroph population and whyestimate the average estrogen levels. In agreement with
is this effect more prominent in females? As demon-the estrous cycle data, D2R-null females have a 70%
strated, neither estrogens or hypothalamic factors seemreduction of estrogen serum content as compared to
to be implicated in the D2R-null mice. Thus, the onlyWT females. Estrogens were also reduced by 20% in
likely explanation is that PRL itself stimulates lactotrophmales. Interestingly, estrogen levels in D2R-null mice
proliferation. Interestingly, this effect appears to bewere very similar in the two genders (females, 8 ng/l;
slow, continuous, and dependent on threshold PRLmales, 9 ng/l). Thus, in contrast to the WT mice, PRL
levels. Male knockouts do have hyperplastic pituitaries,transcription is presumably equally stimulated by estro-
gens in these mice. Nevertheless, D2R-null females still but not as prominent as in age-matched females (Figure
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extracts from mouse mammary gland, one of the major
PRL-R expression sites (Figure 7B) (Jahn et al., 1991).
Interestingly, the intensity of the band in male mouse
pituitaries is weaker than in females (Figure 7B, compare
lanes 7 and 1 and lanes 8 and 2). The comparison of
pituitary extracts from WT and D2R-null mice shows an
increase of PRL-R in knockout animals. This difference
becomes more pronounced as the animals become
older (Figure 7B). Dissection of the IL from the AL shows
that the PRL-R is also expressed in the IL (Figure 7B).
Thus, the hyperplasia correlates with a progressive
induction of PRL-R levels in the pituitary gland of the
D2R-null mice.
Interaction of the PRL-R with PRL is known to lead
to its phosphorylation by the activity of Janus kinases
(JAK) (Rui et al., 1994; Schindler and Darnell, 1995;
Lebrun et al., 1995; Gao et al., 1996). Thus, to show
that the pituitary PRL-R is functional, we probed the
immunoprecipitates with an anti-phosphotyrosine anti-
body. The banding pattern we obtained is indicative ofFigure 7. Expression and Activation of PRL-R in the Pituitary Gland
active receptors since the intensity of the bands ob-of D2R2/2 Mice
tained with the anti-phosphotyrosine antibody corre-(A) RNAse protection analysis of PRL-R mRNA in the pituitary gland
of WT and D2R2/2 mice. Lanes 1 and 2, 4-month-old females. Lanes sponds to those detected with the PRL-R antibody (Fig-
3 and 4, 1-year-old females. Lanes 5 and 6, 4-month-old males. ure 7B).
Lanes 7 and 8, 1-year-old males. MG, WT mouse mammary gland. We conclude that the pituitary hyperplasia observed
H4 histone was used to normalize the quantity of RNA loaded. Re-
in D2R-null mice is dependent on the aberrant PRL levelssults are representative of three independent experiments.
resulting from the lack of dopaminergic inhibition. Thus,(B) The top row shows immunoprecipitation of pituitary extracts
we propose that PRL may play an autocrine role in pitu-from WT and D2R2/2 mice with an anti-JAK2 antibody. Immunopre-
cipitates were revealed with the anti-PRL-R antibody U5. Lanes 1 itary cell proliferation.
and 2, 4-month-old females. Lanes 3 and 4, 8-month-old females.
Lane 5 and 6, 1-year-old females. Lanes 7 and 8, 4-month-old males.
MG, mouse mammary gland. AL and IL indicate extracts from iso- D2R Deficient Females Develop Pituitarylated anterior and intermediate lobes. Tumors by Eight Months of AgeThe bottom row shows immunoprecipitation of pituitary extracts
The increased size of the pituitary gland observed infrom WT and D2R2/2 mice with the JAK2 antibodies. Immunoprecipi-
4-month-old animals prompted us to analyze older ani-tates were revealed with an anti-phosphotyrosine antibody (P-Tyr).
Samples were loaded in the same order as in the top panel. Results mals, to study whether this effect may be amplified with
are representative of three independent experiments. time. Strikingly, the dissection of ten 8- to 14-month-
old D2R-null females revealed the presence of anterior
pituitary tumors in all of the animals analyzed. The tu-
moral growth was independent of whether or not these2A), while PRL plasma levels are sixfold lower in male
than in female knockouts. females had been pregnant or of the number of pregnan-
cies they had had during their life. The pituitary glandThese results strongly support the hypothesis that the
slow developing hyperplasia in D2R-null females is due of knockout males, although enlarged, never showed a
similar hyperplasia at this age. However, in 19-month-to an autocrine effect of PRL on lactotroph cells. How-
ever, a prerequisite for this hypothesis is that functional old D2R-null males, a phenotype similar to the one ex-
hibited by the 8- to 14-month-old D2R-null females wasprolactin receptors (PRL-R) (Boutin et al., 1988) should
be found in the mouse pituitary. To date, the expression observed. In contrast, no signs of hyperplasia were en-
countered in the animals from the control group. Theof PRL-R has been reported only in the rat anterior
pituitary (Morel et al., 1994). Thus, we first performed histological appearance of the AL of one of these pitu-
itaries is illustrated in Figure 8. Cryostat sections stainedRNAse protection analyses to detect the expression of
PRL-R mRNA in the pituitaries of WT and D2R2/2 mice. by hematoxylin-eosin showed that the tumor specifically
affects the AL, with nodular areas and large blood vesselA protected fragment corresponding to the PRL-R was
observed in the pituitaries of WT mice. A fourfold in- infiltration, a typical feature of pituitary adenoma. The
IL is also hyperplastic but still contained and histologi-crease of PRL-R mRNA was found in 4-month-old
D2R-null mice, whereas a 10-fold increase was observed cally well defined. Furthermore, the characteristic three-
lobed structure of the pituitaries is still recognizable.in oldermutants (Figure 7A). Westernblot analyses using
the anti-PRL-R antibodies, performed after immunopre- In order to characterize the cell types present in these
tumors, we performed in situ hybridization of serial pitu-cipitation of pituitary extracts from female and male WT
and D2R-null mice at different ages, confirmed these itary sections from 14-month-old D2R-null females using
probes corresponding to the genes encoding the differ-data. A band corresponding to the PRL-R is present in
the pituitaries of WT and D2R-null animals (Figure 7B). ent hormones. The hyperplastic anterior lobe still con-
tains gonadotrophs expressing b-FSH and b-LH andThe identity of the immunoreactive band obtained with
the PRL-R antibody was confirmed by the use of POMC-positive corticotrophs. The number of thesecells
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is not modified with respect to WT mice, and they appear
sparse in the overgrowing tissue (data not shown). In
sharp contrast, the thyro-somato-lactotroph lineage is
profoundly affected in these pituitaries. We observed a
robust PRL labeling in sections. Indeed, proliferation of
PRL-producing cells is the basis of the tumor, since
there are no regions of the anterior lobes devoid of PRL
expression (Figure 8). Surprisingly, the number of GH-
expressing cells, which was already reduced in younger
animals (Figure 4), is further decreased (Figure 8). In
contrast, an increase of b-TSH positive cells is observed
(Figure 8). It should be pointed out that thyrotrophs rep-
resent only 2%±5% of a normal AL cell population (Gage
et al., 1996). These results indicate that the lack of DA
D2Rs in lactotrophs results in a continuous proliferation
of these cells throughout the animal's life. Lactotroph
proliferation causes a dramatic decrease in the number
of cells expressing GH. As previously suggested, the
somato-mammotroph lineage might follow an alterna-
tive differentiation route, ultimately leading to an over-
production of lactotrophs. The increase of thyrotrophs
could reflect a compensatory mechanism, in which the
continuous transformation of somatotrophs into lacto-
trophs activates the proliferation of this lineage from a
common stem cell (Gage et al., 1996) still present in the
adult (Borrelli et al., 1989). Transcription factor Pit-1/
GHF1 is required for the transcription of the hormones
produced by these cells and for their commitment (Lin
et al., 1992; Andersen and Rosenfeld, 1994). In vitro
studies have shown that the Pit-1 promoter is under
a negative dopaminergic control elicited by the D2Rs
(Elsholtz et al., 1991). We thus analyzed whether the
observed phenotype might involve an upregulation of
Pit-1 in the thyro-somato-mammotrophs of D2R-null
mice. The analysis was conducted on pituitaries of
4- and 14-month-old WT and mutant animals. Pit-1 ex-
pression was confined to the AL in both group of ani-
mals, and the level of expression per cell did not differ
in the mutant animals as compared to WT littermates
(data not shown).
Discussion
The development of the pituitary gland is under the con-
trol of various factors involved in the establishment,
proliferation, and maintainance of cell type (Voss and
Rosenfeld, 1992; Borrelli, 1994). In this paper, we reveal
a central involvement of DA in the control of these func-
tions. Absence of D2R leads to an increased expression
of the hormones produced by the lactotrophs and mela-
notrophs, indicating that, in both cases, DA exerts an
inhibitory control over the expression of these genes.
Interestingly, the histology of the pituitary of young
D2R-null animals shows a clear enlargement of the inter-
mediate and anterior lobes inboth sexes. The expansion
of the lobes is mirrored by a substantial increase of PRL
and POMC gene expression. We show that this increase
Figure 8. Abnormal Growthand HormoneExpression in the Pituitary females. AL, anterior lobe; IL, intermediate lobe; PL, posterior lobe;
of a 14-Month-Old D2R2/2 Female M, tumoral mass.
(A) Hematoxylin-eosin staining of a cryostat section. The figure (B) PRL, GH, and b-TSH in situ hybridization of serial sections from
shows the typical aspect of tumoral pituitaries from aged D2R2/2 the same pituitary as in (A). Scale bar, 500 mm.
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is mainly due to a striking proliferation of the cells that rat anterior pituitary (Morel et al., 1994). Interestingly, a
gradation of PRL-R density has been shown betweenexpress these hormones, the lactotrophs and the mela-
notrophs. Both cell types normally express D2Rs. Thus, the different AL cell types, with the somatotrophs show-
ing the highest expression (Morel et al., 1994). We dem-DA through D2R controls the rate of proliferation of pitu-
itary cells. Importantly, mutant mice lacking the DA onstrate that PRL-Rs are also present in the mouse
pituitary, and we extend this observation to the melano-transporter (Giros et al., 1996) present an increased do-
paminergic tone that causes dwarfism and pituitary hy- trophs in the IL (Figure 7). The PRL-R is present and
activated since it is phosphorylated (Figure 7). The acti-poplasia (BosseÂ et al., 1997 [this issue of Neuron]). In
these mice, the cell number of both the melanotrophs vation of the PRL-R transduction pathway is known to
lead to altered cell proliferation (Mershon et al., 1995).and lactotrophs is greatly reduced, further suggesting
that the principal role of DA in pituitary physiology is at Interestingly, lactotrophs are the last cells to differenti-
ate during pituitary development. Since PRL is first de-the level of cell proliferation.
We have observed that the estrous cycle of D2R-null tected around postnatal day 5 (Frawley and Miller, 1989),
this suggests that the proliferative function of thisfemales looses its strict periodicity (Figure 6) and occurs
only once a month. These results establish a link with hormone might operate following the complete devel-
opment of the other cell types. As mentioned above,the observations that hyperprolactinemia leads to hypo-
estrogenism in humans (Frohman, 1987). It is known that the PRL-Rs are highly concentrated on somatotrophs,
which are able to proliferate also in theadult; conversely,estrogens play a critical role in lactotroph proliferation
as well as in the stimulation of prolactin synthesis (Day lactotrophs are postmitotic cells, as shown from abla-
tion studies (Borrelli et al., 1989). This raises the in-et al., 1990), and it has been proposed that estrogen
might be the factor required for lactotroph growth (Sla- triguing possibility that PRL might mediate lactotroph
proliferation by activating PRL-Rs present on somato-baugh et al., 1981; Carbajo-Perez and Watanabe, 1990;
Voss and Rosenfeld, 1992; Gage et al., 1996). In the trophs, causing them to differentiate into lactotrophs.
The key regulator of such function is the D2R that con-present study, we show that DA is implicated in the
regulation of lactotroph proliferation, since the absence trols PRL expression and release. In the absence of
D2Rs, PRL is continuously secreted, generating the hy-of D2Rs leads to pituitary hyperplasia and tumors. This
process, apparent by the first months of age, becomes perplasia. In keeping with our findings, there is evidence
that one of the most common pituitary tumors, the pro-extremely pronounced in 8- to 10-month-old female
D2R-null mice, indicating the presence of a constant lactinoma, originates from a lack of dopaminergic inhibi-
tion (Wood et al., 1991). These tumors normally regressproliferative stimulus on lactotrophs. This is not depen-
dent on alterations of hypothalamic releasing factors following D2R agonist treatment, and in the most malig-
nant cases these tissues do not respond to this treat-such as TRH and VIP as demonstrated by our results.
Estrogen stimulation of lactotroph growth also cannot ment, suggesting a total loss of dopaminergic control.
Plasticity in lactotroph growth can be influenced byaccount for this effect, since D2R-null females have es-
trogen plasma levels reduced by 70% with respect to different factors. It has been shown that overexpression
of nerve growth factor (NGF) under the control of theWT mice. Interestingly, D2R-null males and females have
similar estrogen levels, although sexual differences are prolactin promoter in transgenic mice results in high
PRL synthesis and lactotroph hyperplasia (Borrelli et al.,present at the level of PRL plasma concentration. These
differences can only be explained by the presence of a 1992), a pituitary phenotype similar to the one described
in this paper. Interestingly, the presence of NGF recep-much larger number of lactotrophs in females versus
male mice. Our data demonstrate that lactotroph hyper- tors on lactotrophs has been reported recently, and the
trophic effect of NGF on these cells has been demon-plasia is dictated by threshold levels of PRL. Indeed,
both the hyperplasia and the tumor formation occur later strated (Missale et al., 1996a, 1996b). The activation
of the signal transduction pathways by PRL and NGF,in males than in females, due to lower PRL levels in
males. These results lead us to propose that PRL itself although done through different signal transduction
mechanisms (Schindler and Darnell, 1995; Segal andplays an autocrine role in pituitary cell proliferation.
D2R-null females present alterations of the thyro- Greenberg, 1996), lead to a similar effect on cell prolifer-
ation. It is tempting to speculate that during normalsomato-mammotroph lineage. The number of somato-
trophs is reduced while the thyrotrophs are increased pituitary cell differentiation NGF, via an autocrine mech-
anism or through the stimulation of PRL synthesis, couldin the hyperplastic pituitaries. It is conceivable that in
these animals more somatotrophs are transformed into be responsible for lactotroph growth. In this paper, we
show that only the lactotrophs and melanotrophs arelactotrophs. This process is likely to be triggered as
soon as PRL levels increase above a certain threshold, affected by the elevation of PRL, despite the presence
of PRL-R on all cell types of the anterior pituitary. Mela-being evident in 4-month-old mice and then increasing
in older animals. This effect also leads to an increase in notrophs and lactotrophs are the only two cell types
expressing D2Rs and consequently are the only ones tothyrotrophs. These cells probably derive from precursor
stem cells still present in the adult (Borrelli et al., 1989). have lost the hypothalamic inhibitory control of growth
as a result of D2R ablation.These results indicate that DA is of fundamental impor-
tance in the maintainance of the adult pituitary pheno- Our results illustrate the critical role of D2R in the
pituitary and on the neuroendocrine control of physio-type by repressing synthesis and release of PRL, and
they also reveal a pivotal function for prolactin in pitu- logical functions. They also assign a new and important
role to PRL in pituitary cell proliferation. We proposeitary cell development.
Previously, PRL-R expression was documented in the that receptor-mediated activation of the tyrosine kinase
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K (150 mg/ml), extracted with phenol-chloroform, and precipitatedpathway might play a key role in the control of pituitary
with ethanol. Protected fragments were run on a 6% polyacrylamide/8cell proliferation and maintenance.
M urea gel. Autoradiograms were analyzed with a Biorad GS-700
Imaging Densitometer. H4 histone was used as an internal standard
Experimental Procedures for RNA quantitation.
Mice
In Situ HybridizationD2R mutants (Baik et al., 1995) had a mixed 129SV3C57Bl/6 genetic
Pituitary and brain cryostat sections (10 mm) were prepared frombackground, with a 75% contribution of C57Bl/6. Animals were
WT and D2R2/2 mice. Ten adult (4- to 14-month-old) females of bothhoused in a 12 hr light/dark cycle with food and water available ad
genotypes were used for the analysis of hormone expression. TRHlibitum. Wild-type and knockout littermates obtained by crossing of
and VIP expression in the hypothalamus was analyzed in three WTheterozygotes were used in all experiments.
and three D2R2/2 adult females. In situ hybridization was performed
as previously described (Baik et al., 1995). The specificity of the in
Ligand Binding
situ hybridization results was confirmed by the use of sense strand
Four-month-old wild-type (n 5 3) and mutant (n 5 3) mice were
riboprobes, which showed no detectable signals. The number of
sacrificed after anesthesia (Rompun, Bayer). Pituitary cryostat sec- GH and b-TSH positive cells was estimated by counting clusters of
tions (10 mm) were mounted on gelatine-coated slides and stored grains, on toluidine-blue counterstained nuclei, five times higher
at 2808C. Sections were brought to room temperature, washed in than background. For GH cells, numbers (6 SD) are given as profile
HEPES buffer (50 mM Hepes [pH 7.5], 1 mM EDTA, and 0.1% BSA) densities of the number of cells/unit, each unit corresponding to 0.1
for 5 min and incubated for 1 hr at room temperature with 0.3 nM mm2. Two hundred different fields were counted from six serial
[125I]-iodosulpride (2000 Ci/mmol; Amersham, UK) in Tris-buffered sections from four WT and four D2R2/2 pituitaries. For b-TSH thesalt solution (50 mM Tris [pH 7.5], 120 mM NaCl, 5 mM KCl, 1 mM number (6 SD) of positive cells was evaluated on entire sections,
CaCl2, 1 mM MgCl2, 5 nM ascorbic acid, and 10 mM hydroxyquino- due to the low density of this cell type; 24 sections from four different
line). Nonspecific binding was determined with 5 mM cold sulpiride.
pituitaries of each genotype were used. Numbers are estimates of
After incubation, sections were washed twice for 2 min in ice-cold
profile densities and, as such, have the caveat of being offset by
Tris-buffered salt solution and dipped in cold distilled water. Sec-
changes in the volume of the pituitaries. Data were analyzed by the




Blood samples were centrifuged at 4000 rpm for 15 min. Sera wereCryostat and paraffin sections of pituitary glands from 12 WT and
removed and stored at 2208C. PRL was measured by a mPRL RIA14 knockout mice of both sexes were used. For paraffin sectioning,
kit, obtained from Dr. A. F. Parlow (Pituitary Hormones and Antiserapituitaries were fixed in Bouin's fixative, embedded in paraffin, and
Center, UCLA Medical Center, CA). GH and b-TSH RIA kits werecut with a microtome (10 mm).Sections werestained by hematoxylin-
from Amersham (UK) and the estrogen RIA kit was from Biomerieuxeosin or by DAPI staining. The surface (6 SD) of the IL of WT and
(France).D2R-null mice was estimated by analyzing sections, all of which
contained a well defined IL, using the NIH Image 1.59 software. A
Immunoblotting and Immunoprecipitation Analysissimilar number of cells/unit (1 unit 5 0.1 mm2) was evaluated by
PRL-R content in pituitaries from six animals of both sexes andcounting DAPI stained nuclei from 40 sections from six animals of
genotypes was analyzed in three independent experiments. Pituitar-each genotype. Numbers are estimates of profile densities and, as
ies were rapidly dissected, frozen, and homogenized in 100 ml ofsuch, have the caveat of being offset by changes in the volume of
lysis buffer (50 mM HEPES [pH 7.5], 150 mM NaCl, 5 mM EDTA,the pituitaries.
0.5%Triton X-100, 1 mMPMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin,For the analysis of the estrous cycle, vaginal smears from five
1 mM sodium orthovanadate, and 50 mM NaF). Lysates were centri-WT and five D2R2/2 adult mice were collected every day for a 40 day
fuged (13,000 rpm for 30 min at 48C), and protein concentration wasperiod. Smears were streaked on slides andstained by hematoxylin-
estimated by Bradford. PRL-R immunoprecipitations were per-eosin.
formed using JAK2 antibodies. One milligram of total proteins in 1
ml of lysis buffer was precleared with preimmune rabbit serum andRNA Analysis
then incubatedfor 2 hr at 48C with 2 ml of anti-mouse JAK2 polyclonalGH, PRL, b-TSH, POMC, and PRL-R cDNAs were obtained by RT-
antibody (UBI, NY). Immunoprecipitates were collected with proteinPCR from mouse pituitary RNA using oligos based on published
A-sepharose (Pharmacia) and resolved on SDS-PAGE.After blotting,sequences (GenBank accession numbers: X02891, X02892, J00644,
filters were probed with U5 anti-rat PRL-R antibody (Interchim,J00610, and L13593). TRH and VIP probes were amplified from
France) or PT-66 anti-phosphotyrosine monoclonal antibodygenomic DNA (GenBank accession numbers: X59387 and X74297).
(Sigma). Signals were revealed by enhanced chemiluminescenceb-LH, aGSU and b-FSH cDNAs were a generous gift from Dr. P.
(ECL; Amersham, UK) and quantified with a Biorad GS-700 ImagingMellon.
Densitometer.
Northern Blot Analysis
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